DEEPAKNTR

- Deepak Chem Tech Limited (wholly-owned subsidiary) received ₹175 Cr (₹95 Cr from Deepak Phenolics, ₹80 Cr from Deepak Nitrite) via 9% Optionally Convertible Redeemable Preference Shares (OCRPS). - Funds will strengthen DCTL's capital base, support project expenses and general corporate purposes. - Transaction completed on August 26, 2026, for internal growth within the chemical business.

- Deepak Nitrite's subsidiary, Deepak Chem Tech Limited, settled a violation under the Occupational Safety, Health and Working Condition Code, 2020. - A Settlement Order was passed on August 25, 2026, involving a payment of ₹3,00,000. - The company stated there will be no material financial impact.

- Mr. Puneet Sharma, SBU Head - Life Sciences, has resigned from Deepak Nitrite Limited, effective from the close of business hours on 21st August 2026. He is taking up an opportunity outside the organisation.

- The Q1 FY27 earnings conference call highlighted an improving business trajectory driven by better market conditions and operational efficiencies. - MIBK, MIBC, and acetophenone projects are scheduled for commissioning in August/Q2 FY27, expected to strengthen downstream integration and margins. - The integrated polycarbonate project is on track for H2 FY28 commissioning, with Bisphenol A (BPA) to follow a few months later. - Of the INR 11,500 Cr capex for the integration project, approx. INR 3,000-3,200 Cr will be spent by FY27-end, with another INR 3,000 Cr planned for FY28. - Peak debt for the project is estimated around INR 8,000-8,500 Cr, maintaining a comfortable debt-to-equity ratio below 1. - Management expressed optimism for the medium-to-long term outlook, citing healthy demand, new capacities, and competitive raw material sourcing. - The phenol plant aims to achieve 4 lakh tonnes annual production in the short to medium term.

- Shri Dileep Choksi ceased to be an Independent Director, effective August 7, 2026. - The company has disclosed the updated composition of its Board of Directors.

- Shri Dileep Choksi ceased to be an Independent Director of Deepak Nitrite Limited with effect from August 7, 2026, upon completion of his second term.

- Deepak Chem Tech Limited, a wholly owned subsidiary of Deepak Nitrite Limited, has commissioned manufacturing operations for its Methyl Isobutyl Ketone & Methyl Isobutyl Carbinol Plant in Dahej, Gujarat on August 6, 2026. - The total capital expenditure incurred for this project is approximately ₹735 Crores.

- Deepak Nitrite Limited submitted the audio/video recording of the Q1 & FY 2027 Earnings Conference Call. - The call was held on August 6, 2026. - The recording is available on the company's website.

- The 55th Annual General Meeting (AGM) of Deepak Nitrite Limited was held on August 5, 2026. - All resolutions placed before the AGM, including the adoption of standalone and consolidated financial statements for the fiscal year ended March 31, 2026, were passed with requisite majority. - A dividend of ₹7.50 (375%) per equity share of face value ₹2.00 was declared. - The re-appointment of Shri Girish Satarkar as director, appointment of Shri Anant Pande as director and Executive Director & CMO, and elevation and appointment of Shri Maulik Mehta and Shri Meghav Mehta as Deputy Managing Directors were approved.

- The 55th Annual General Meeting (AGM) was held on August 5, 2026, through video conferencing. - Members approved the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026. - A dividend of ₹7.50 per equity share (375%) was declared for the financial year ended March 31, 2026. - The AGM approved the appointment and re-appointment of several directors, including Independent and Executive Directors.

- Deepak Nitrite's subsidiary approved a Bisphenol A manufacturing project. - Capacity: upto 240 KTA with an investment of approx ₹2,500 Crores. - Project will be funded by a mix of debt and equity. - Aims to serve captive requirements and the growing Indian market.

- Deepak Nitrite Limited appointed Shri Lohit Shringi as Chief Executive Officer for its Advanced Intermediates Business. - The appointment is effective from August 4, 2026, as approved by the Board of Directors on the same date.

- Consolidated Revenue ₹2,577.60 Cr vs ₹1,889.88 Cr (▲36.39% YoY) - EBITDA ₹540.19 Cr vs ₹189.56 Cr (▲185.07% YoY) - PAT ₹345.01 Cr vs ₹112.25 Cr (▲207.36% YoY) - EBITDA Margin 20.96% vs 10.03% (▲1093 bps)

- Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite, issued 9% Optionally Convertible Redeemable Preference Shares (OCRPS) aggregating to ₹120.00 Crores to Deepak Phenolics Limited (DPL), another wholly-owned subsidiary. - The investment aims to strengthen DCTL's capital base and support its project expenses and general corporate purposes. - DCTL's turnover grew from ₹0.86 Crores in FY 2023-24 to ₹172.23 Crores in FY 2025-26.

- Concall Schedule - Concall Date: Thursday, 6 August, 2026 - Concall Time: 3:30 PM IST - Purpose: To discuss the Financial Results for the first Quarter ended 30th June, 2026 (Q1 FY27). - Universal Dial-in: +91 22 6280 1259 / +91 22 7115 8160

- Deepak Nitrite Limited executed a Deed of Guarantee on July 23, 2026, for a US $ 78.43 Million term loan for its 51% subsidiary, Deepak Oman Industries (SFZ) LLC. - This creates a contingent liability for the company, which will charge a guarantee commission from the subsidiary.

New Filing detected. See link for details.

- The 55th Annual General Meeting (AGM) will be held on Wednesday, August 5, 2026, at 11:30 AM (IST) through Video Conferencing. - The Record Date for the AGM and determining members eligible for dividend (if declared) is fixed as Monday, July 27, 2026.

- The 55th Annual General Meeting (AGM) will be held on August 5, 2026, at 11:30 AM (IST) via Video Conferencing. - The Record Date for the AGM and for determining eligibility for dividend (if declared) is fixed as July 27, 2026.

- Trading window for Designated Persons and Immediate Relatives to close from July 1, 2026. - This closure is ahead of the Q1 FY27 unaudited financial results for the quarter ending June 30, 2026, and will reopen 48 hours post-declaration.